- Home
- SEPN vs DBL Comparison
SEPN vs DBL Comparison
Compare SEPN & DBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEPN
- DBL
- Stock Information
- Founded
- SEPN 2022
- DBL 2011
- Country
- SEPN United States
- DBL United States
- Employees
- SEPN N/A
- DBL N/A
- Industry
- SEPN
- DBL
- Sector
- SEPN
- DBL
- Exchange
- SEPN NYSE
- DBL Nasdaq
- Market Cap
- SEPN 311.6M
- DBL 280.4M
- IPO Year
- SEPN 2024
- DBL N/A
- Fundamental
- Price
- SEPN $9.25
- DBL $15.64
- Analyst Decision
- SEPN Buy
- DBL
- Analyst Count
- SEPN 4
- DBL 0
- Target Price
- SEPN $27.00
- DBL N/A
- AVG Volume (30 Days)
- SEPN 2.6M
- DBL 61.0K
- Earning Date
- SEPN 05-15-2025
- DBL 01-01-0001
- Dividend Yield
- SEPN N/A
- DBL 8.67%
- EPS Growth
- SEPN N/A
- DBL N/A
- EPS
- SEPN N/A
- DBL N/A
- Revenue
- SEPN $977,000.00
- DBL N/A
- Revenue This Year
- SEPN N/A
- DBL N/A
- Revenue Next Year
- SEPN N/A
- DBL N/A
- P/E Ratio
- SEPN N/A
- DBL N/A
- Revenue Growth
- SEPN 108.76
- DBL N/A
- 52 Week Low
- SEPN $4.17
- DBL $13.75
- 52 Week High
- SEPN $28.99
- DBL $15.70
- Technical
- Relative Strength Index (RSI)
- SEPN N/A
- DBL 57.74
- Support Level
- SEPN N/A
- DBL $15.36
- Resistance Level
- SEPN N/A
- DBL $15.60
- Average True Range (ATR)
- SEPN 0.00
- DBL 0.19
- MACD
- SEPN 0.00
- DBL 0.02
- Stochastic Oscillator
- SEPN 0.00
- DBL 88.00
About SEPN SEPTERNA INC
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.
About DBL DoubleLine Opportunistic Credit Fund of Beneficial Interest
Doubleline Opportunistic Credit Fund operates as a closed-end management investment company. Its investment objective is to seek a high total investment return by providing a high level of current income and the potential for capital appreciation. The Fund invests in debt securities, residential and commercial mortgage-backed securities, asset-backed securities, U.S. Government securities, corporate debt, international sovereign debt, and short-term investments.